Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.390
+0.100 (7.75%)
Dec 20, 2024, 4:00 PM EST - Market closed
Neuronetics Revenue
Neuronetics had revenue of $18.53M in the quarter ending September 30, 2024, with 3.61% growth. This brings the company's revenue in the last twelve months to $72.71M, up 5.03% year-over-year. In the year 2023, Neuronetics had annual revenue of $71.35M with 9.42% growth.
Revenue (ttm)
$72.71M
Revenue Growth
+5.03%
P/S Ratio
0.57
Revenue / Employee
$358,182
Employees
203
Market Cap
42.18M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSTIM News
- 3 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 days ago - Neuronetics and Greenbrook TMS Announce Closing of Transaction - GlobeNewsWire
- 4 weeks ago - Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 5 weeks ago - Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 7 weeks ago - Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call - GlobeNewsWire
- 2 months ago - NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression - GlobeNewsWire